ProFund Advisors »

Summit Therapeutics shares owned by ProFund Advisors

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by ProFund Advisors from 13F filings

Historical chart of ProFund Advisors investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by ProFund Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by ProFund Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.4M 70k 20.66
2025-06-30 $844k 40k 21.28
2025-03-31 $910k 47k 19.29
2024-12-31 $1.1M 59k 17.85
2024-09-30 $489k 22k 21.90
2024-06-30 $243k 31k 7.80
2024-03-31 $418k 101k 4.14